(Q60209721)
Statements
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study (English)
André J Scheen
Priscilla Hollander
Michael D Jensen
Luc F Van Gaal
RIO-Diabetes Study Group
1 November 2006